0.0000 (0.0000%)
  • Bid / Lots
    0.6000/ 2
  • Ask / Lots
    1.5400/ 1
  • Open / Previous Close
    0.0000 / 1.1800
  • Day Range
  • 52 Week Range
    Low 0.7711
    High 9.1300
  • Volume
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 1.2
09:32 ET41911.2
09:42 ET1001.19
09:46 ET2001.19
09:51 ET3331.1898
09:53 ET8771.19
10:08 ET11001.19
10:13 ET75921.2
10:15 ET1001.2
10:20 ET1001.19
10:31 ET4001.1801
10:44 ET1001.1801
10:49 ET46001.21
10:51 ET10001.2
11:00 ET3001.21
11:18 ET5001.21
11:21 ET57001.205
11:32 ET10001.23
11:36 ET4001.23
11:48 ET1001.22
11:52 ET1001.2
11:57 ET10001.22
12:01 ET5001.18
12:06 ET1001.195
12:33 ET11971.19
12:51 ET1001.19
01:00 ET22001.19
01:02 ET32961.195
01:04 ET63841.21
01:49 ET1001.19
02:00 ET271501.19
02:02 ET431141.18
02:20 ET30001.2
02:21 ET10001.2
02:48 ET1001.1918
02:50 ET6001.1952
03:14 ET1001.195
03:28 ET79981.22
03:32 ET43001.19
03:35 ET19801.2
03:42 ET52001.205
03:51 ET6981.2
03:53 ET24501.2
03:55 ET19701.18
03:57 ET11001.19
04:00 ET323661.18
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLMDX
LumiraDx Ltd
United StatesARAY
Accuray Inc
United StatesTRHC
Tabula Rasa HealthCare Inc
United StatesBBLN
Babylon Holdings Ltd
United StatesCPSI
Computer Programs and Systems Inc
United StatesCUTR
Cutera Inc
As of 2023-02-09

Company Information

LumiraDx Limited is a United Kingdom-based diagnostics company. The Company is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need. The Company has developed and launched the LumiraDx Platform, which is an integrated system comprised of small, microfluidic test strips and secure digital connectivity. Its diagnostic testing solutions are being deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The Company has developed and received regulatory approvals for approximately 11 diagnostic tests for use with its instrument. In addition, the Company has a portfolio of COVID-19 testing solutions from the lab to point of need.

Contact Information

Windward 3, Regatta Office Park PO Box 1350GRAND CAYMAN, Cayman Islands KY1-1108


Chairman of the Board, Chief Executive Officer, Co-Founder, Director
Ron Zwanziger
President - North American Commercial Operations
Peter Scheu
Co-Founder, Chief Technology Officer, Director
Dave Scott
Co-Founder, Chief Scientific Officer, Director
Jerry McAleer
Chief Financial Officer, Vice President, Global Operations
Dorian LeBlanc

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.